A newly developed 3D-printable tissue scaffold is designed to break down in the body once it has served its medical purpose. The 4Degra biodegradable and customizable biomaterial could provide support for healing across tissue types, including soft tissue post-surgery or for support in orthopedics, and it could eliminate the potential complications with long-term devices or removal.
Four new bulk substances are up for inclusion on the list of active pharmaceutical ingredients that outsourcing facilities can use in drug compounding under section 503B of the Federal Food, Drug, and Cosmetic Act, according to a proposal from the US Food and Drug Administration (FDA).
Enforcement Report - Week of March 22, 2017
Synergy Issues Voluntary Recall of the Products Due to Lack of Quality Assurance